No Data
No Data
Express News | Monopar Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results and Announced a 1-for-5 Reverse Stock Split
Monopar Therapeutics | 10-Q: Q2 2024 Earnings Report
Express News | Monopar Therapeutics Q2 EPS $(0.10) Misses $(0.09) Estimate
Express News | Monopar Therapeutics Inc: Qtrly Shr Loss $0.10
Monopar Therapeutics 2Q Research and Development Expenses $1.1M >MNPR
Express News | Monopar Therapeutics: Anticipate to Seek to Raise Additional Capital Within Next 12 Months to Fund Future Operations
No Data